HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$2.90
Day range
$2.88 - $3.12
Year range
$1.59 - $4.09
Market cap
44.70M USD
Avg Volume
120.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 121.00K | 6.14% |
Operating expense | 13.21M | 108.13% |
Net income | -12.16M | -84.64% |
Net profit margin | -10.05K | -73.96% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.18M | 354.33% |
Total assets | 76.20M | 295.48% |
Total liabilities | 12.66M | 63.12% |
Total equity | 63.54M | — |
Shares outstanding | 14.75M | — |
Price to book | 0.67 | — |
Return on assets | -40.19% | — |
Return on capital | -47.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.16M | -84.64% |
Cash from operations | -8.51M | -65.18% |
Cash from investing | -4.82M | — |
Cash from financing | -2.00K | 95.74% |
Net change in cash | -13.34M | -156.51% |
Free cash flow | -4.22M | -56.47% |
About
Founded
2003
Headquarters
Website
Employees
10
